Townsend Richard Nolan

CIK 00019952181 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001995218

Recent Transactions

46 trades

Award
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2026-03-13$2.64/sh+2,623→ 395,106 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2026-02-18$6.38/sh−10,173→ 392,483 total
Award
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2026-02-04+646,665→ 646,665 total
Award
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2026-02-04+161,665→ 402,656 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-11-18$9.27/sh−1,127→ 240,991 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-10-17$9.56/sh−148→ 242,118 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-10-17$8.94/sh−12,985→ 242,266 total
Award
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-10-15+33,000→ 255,251 total
Award
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-09-12$2.64/sh+2,193→ 222,251 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-08-18$4.67/sh−2,735→ 220,058 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-08-18$4.67/sh−1,115→ 220,058 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-05-16$2.77/sh−1,074→ 221,173 total
Award
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-03-14$2.61/sh+2,128→ 222,247 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-02-19$4.41/sh−4,326→ 220,119 total
Award
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2025-01-07+207,500→ 207,500 total
Award
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2025-01-07+103,750→ 224,445 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2024-12-10−2,500→ 118,655 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-12-10$8.20/sh−2,500→ 120,695 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-12-10$2.33/sh+2,500→ 123,195 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-11-11$7.82/sh−2,500→ 120,695 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2024-11-11−2,500→ 121,155 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-11-11$2.33/sh+2,500→ 123,195 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-10-10$8.10/sh−5,000→ 120,695 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2024-10-10−5,000→ 123,655 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-10-10$2.33/sh+5,000→ 125,695 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2024-09-10−5,000→ 128,655 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-09-10$2.33/sh+5,000→ 125,695 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-09-10$10.65/sh−5,000→ 120,695 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-08-12$11.53/sh−5,000→ 120,695 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-08-12$2.33/sh+5,000→ 125,695 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2024-08-12−5,000→ 133,655 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-07-11$17.06/sh−27,931→ 120,795 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-07-11$19.06/sh−100→ 120,695 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-07-10$2.33/sh+5,000→ 175,695 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2024-07-10−5,000→ 138,655 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-07-10$16.85/sh−3,347→ 148,726 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-07-10$16.45/sh−23,622→ 152,073 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-06-10$2.33/sh+5,000→ 175,695 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-06-10$18.18/sh−2,038→ 170,695 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Stock Option (right to buy)
2024-06-10−5,000→ 143,655 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-06-10$17.29/sh−2,962→ 172,733 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-05-13$2.33/sh+5,000→ 175,695 total
Sale
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-05-13$13.22/sh−5,000→ 170,695 total
Exercise/Conversion
Lexeo Therapeutics, Inc.$LXEO
Stock Option (Right to Buy)
2024-05-13$2.33/sh−5,000→ 148,655 total
Award
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2024-01-05+43,750→ 170,695 total
Award
Lexeo Therapeutics, Inc.$LXEO
Stock Option (Right to Buy)
2024-01-05+262,500→ 262,500 total

Companies

Lexeo Therapeutics, Inc.
Director, Chief Executive Officer
$LXEO

Recent Filings

Address

C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, FLOOR 6

NEW YORK, NY, 10010

View on SEC.gov